The Journal for Nurse Practitioners
Volume 3, Issue 2 , Pages 110-115 , February 2007

Addressing the Physiologic and Psychological Symptoms Associated with Carcinoid Tumors

  • Lora J. McIntyre, MSN, RN

      Affiliations

    • Lora J. McIntyre, MSN, RN, and Tamra J. Courey, MSN, RN, CS, are assistant professors at Kent State University, Ashtabula Regional Campus, in Ashtabula, Ohio. Courey can be reached at. Neither author has relationships with business or industry to disclose.
    • ,
  • Tamra J. Courey, MSN, RN, CS

      Affiliations

    • Lora J. McIntyre, MSN, RN, and Tamra J. Courey, MSN, RN, CS, are assistant professors at Kent State University, Ashtabula Regional Campus, in Ashtabula, Ohio. Courey can be reached at. Neither author has relationships with business or industry to disclose.

References 

  1. Bell HK , Poston GJ , Vora J , Wilson NJ . Cutaneous manifestations of the malignant carcinoid syndrome . Br J Derm. . 2005;152(1):71–75
  2. Tierney L , McPhee S , Papadakis M . Current medical diagnosis and treatment . New York, NY: Lange Medical Books/McGraw-Hill; 2001;
  3. Schnirer II , Yao JC , Ajani JA . Carcinoid: a comprehensive review . Acta Oncol. . 2003;42(7):672–692
  4. Shiel W . Carcinoid syndrome . Available at: www.medicinenet.com Accessed July 5, 2005.
  5. Carcinoid Cancer Foundation  . A review of carcinoid disease . Available at: www.carcinoid.org Accessed July 5, 2005.
  6. Cancer Reference Information  . What are the risk factors for gastrointestinal carcinoid tumors? . Available at: www.cancer.org Accessed July 5, 2006.
  7. Wolf F . Preclinical and clinical pharmacology of the 5-HT3 receptor antagonists . Scand J Rheumatol. . 2000;29(113):37–45
  8. Marrs J . Focus on carcinoid tumors . Clin J Oncol Nurs. . 2004;8(6):660–661
  9. Novartis Pharmacueticals  . Epidemiology and pathophysiology . Available at: www.carcinoidinfo.com Accessed July 5, 2006.
  10. Ahlman H , Nilsson O , Olausson M . Interventional treatment of the carcinoid syndrome . Neuroendocrinology . 2004;80(suppl 1):67–73
  11. Dierdorf SF . Carcinoid tumor and carcinoid syndrome . Curr Opin Anaesthesiol. . 2003;16(3):343–347
  12. Russo S , Nielen MM , Boon JC , et al.   Neuropsychological investigation into the carcinoid syndrome . Psychopharmacology . 2003;168(3):324–328 (Berl).
  13. Stenman UH . Platelet serotonin 5-HT2A receptor binding in patients with carcinoid tumor[editorial] . Scand J Lab Invest. . 2004;64(1):1–2
  14. Cancer Reference Information  . What's new in gastrointestinal carcinoid tumor research and treatment? . Available at: www.cancer.org Accessed July 27, 2006.
  15. MedicineNet  . Carcinoid syndrome: how are carcinoid tumors and carcinoid syndrome treated? . Available at: www.medicinenet.com Accessed July 27, 2006.
  16. Helbecque N , Sparks L , Hunsaker JC , Amouyel P . The serotonin transporter promoter polymorphism and suicide . Neurosci Lett. . 2006;400(1/2):13–15
  17. Hariri AR , Brown SM . Serotonin . Am J Psychiatry . 2006;163(1):12
  18. American Psychiatric Association  . Diagnostic and statistical manual of mental disorders . 4th ed. Washington, DC: American Psychiatric Association; 2000; text revision.

PII: S1555-4155(06)00887-7

doi: 10.1016/j.nurpra.2006.12.002

The Journal for Nurse Practitioners
Volume 3, Issue 2 , Pages 110-115 , February 2007

Article Tools